Jin San Yoo

Dr. Jin-San YOO, president and CEO of PharmAbcine, Inc. in South Korea, founded PharmAbcine in 2008 as a spin-off venture company from KRIBB (Korea Research Institute of Biosciences and Biotechnology) with initial funding from Novartis. Before founding PharmAbcine, he served as a head of "The Therapeutic Antibody Center" at KRIBB and director of Therapeutic Antibody Division at LG Life Sciences. Dr. YOO studied microbiology and organic chemistry at Georg-August University Gottingen and received MS and PhD in the field of molecular cell biology at the Max-Planck-Institute for Biophysical Chemistry and was acting as HHMI fellow at Stanford University School of Medicine and as TSRI senior associate at The Scripps Research Institute.